Schroder Investment Management Group decreased its position in shares of Tenet Healthcare Co. (NYSE:THC - Free Report) by 62.3% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 23,214 shares of the company's stock after selling 38,398 shares during the period. Schroder Investment Management Group's holdings in Tenet Healthcare were worth $2,912,000 as of its most recent SEC filing.
Other large investors also recently bought and sold shares of the company. WR Wealth Planners LLC grew its position in shares of Tenet Healthcare by 2,836.4% during the 4th quarter. WR Wealth Planners LLC now owns 323 shares of the company's stock valued at $41,000 after buying an additional 312 shares during the last quarter. Smartleaf Asset Management LLC grew its position in Tenet Healthcare by 30.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 471 shares of the company's stock worth $59,000 after acquiring an additional 110 shares in the last quarter. Kestra Investment Management LLC bought a new stake in Tenet Healthcare in the 4th quarter valued at $60,000. Wilmington Savings Fund Society FSB raised its stake in shares of Tenet Healthcare by 1,352.8% in the 4th quarter. Wilmington Savings Fund Society FSB now owns 523 shares of the company's stock valued at $66,000 after buying an additional 487 shares in the last quarter. Finally, Spire Wealth Management increased its position in shares of Tenet Healthcare by 19.5% during the 4th quarter. Spire Wealth Management now owns 558 shares of the company's stock worth $70,000 after purchasing an additional 91 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company's stock.
Tenet Healthcare Stock Performance
Shares of THC stock traded down $4.93 on Thursday, hitting $126.14. The company had a trading volume of 137,481 shares, compared to its average volume of 1,517,310. The firm has a market cap of $12.00 billion, a P/E ratio of 3.91, a price-to-earnings-growth ratio of 1.02 and a beta of 1.77. Tenet Healthcare Co. has a twelve month low of $90.03 and a twelve month high of $171.20. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. The company has a 50-day moving average price of $130.52 and a 200-day moving average price of $140.18.
Tenet Healthcare (NYSE:THC - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, topping the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. As a group, equities research analysts predict that Tenet Healthcare Co. will post 12.24 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on THC. JPMorgan Chase & Co. reissued an "overweight" rating and set a $175.00 price objective on shares of Tenet Healthcare in a research note on Tuesday, December 17th. Morgan Stanley assumed coverage on Tenet Healthcare in a research note on Wednesday, March 26th. They issued an "overweight" rating and a $165.00 price target for the company. StockNews.com raised Tenet Healthcare from a "hold" rating to a "buy" rating in a research note on Thursday, March 13th. Barclays cut their price target on Tenet Healthcare from $190.00 to $161.00 and set an "overweight" rating on the stock in a report on Thursday, February 13th. Finally, The Goldman Sachs Group downgraded Tenet Healthcare from a "buy" rating to a "neutral" rating and cut their price target for the stock from $196.00 to $140.00 in a research note on Monday, December 16th. Three research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Tenet Healthcare has an average rating of "Moderate Buy" and an average target price of $166.33.
Check Out Our Latest Report on THC
Insider Buying and Selling at Tenet Healthcare
In related news, Director J Robert Kerrey sold 9,525 shares of Tenet Healthcare stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the transaction, the director now directly owns 27,378 shares in the company, valued at $3,434,022.54. The trade was a 25.81 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.93% of the stock is owned by insiders.
About Tenet Healthcare
(
Free Report)
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Articles
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
